Here are 14 recent news updates on key gastroenterology and endoscopy companies.
A recent study found Medigus' MUSE system is a safe minimally-invasive alternative for the long-term treatment of gastroesophageal reflux disease.
C2 Therapeutics presented data from four separate clinical studies at Digestive Disease Week 2016 that found the company's CryoBalloon Focal Ablation System to be safe and effective.
EndoChoice released its RescueNet retrieval device.
EndoChoice received FDA clearance for its new Orca sterile, single-use air/water and suction valves for Olympus 160, 180 and 190 Series flexible endoscopes.
The FDA cleared Avantis Medical Systems' Third Eye Panoramic device as a reusable device for colonoscopies.
gMed received Black Book Rankings' award for Top Ambulatory EHR for gastroenterology for the sixth year in a row.
A new study shows there may be substantial payer cost savings associated with radiofrequency energy treatment of GERD patients, such as Mederi Therapeutics' Stretta therapy, as compared to treatment with medical management or fundoplication.
An endoscopist's knowledge of a positive Cologuard test, by Exact Sciences, improved colonoscopy performance, according to a Rochester, Minn.-based Mayo Clinic poster presentation at the 2016 Digestive Disease Week in San Diego.
Apollo Endosurgery launched the ORBERA Coach platform, a telehealth program.
Compulink Business Systems unveiled Gastroenterology Advantage, an EHR solution for gastroenterologists.
Pentax Medical acquired more than 90 percent of shares in Simmedica.
Frost & Sullivan selected CapsoVision as the recipient of its 2016 European Enabling Technology Leadership award.
PENTAX Medical launched the OPTIVISTA EPK-I7010 video processor in the U.S. market.
NinePoint Medical completed the primary phase of its registry for high resolution optical imaging of the esophagus using the NvisionVLE Imaging System.